Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...
Patent
1980-12-01
1982-09-28
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
Synthetic or structurally-modified peptidoglycan or...
A61K 31335, A61K 31215, C07C 6974, C07C 5911
Patent
active
043518443
ABSTRACT:
Hydrogenation of the natural fermentation product, mevinolin, MK-803, results in the production of dihydro- and tetra-hydro derivatives and hydrogenation of the naturally occurring dihydromevinolin results in the formation of a tetrahydro derivative. These several products with the exception of cis-(4.alpha..beta., 8.alpha..beta.-)-tetrahydromevinolin are potent inhibitors of cholesterol biosynthesis.
REFERENCES:
patent: 3072709 (1963-01-01), Saucy et al.
patent: 3344169 (1967-09-01), Los
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4282155 (1981-08-01), Smith et al.
patent: 4293446 (1981-10-01), Willard
patent: 4294846 (1981-10-01), Albers-Schonberg et al.
patent: 4319039 (1982-03-01), Albers-Schonberg et al.
patent: 4323648 (1982-04-01), Tanzawa et al.
Kuo Chan-Hwa
Patchett Arthur A.
Love Ethel G.
Merck & Co. , Inc.
Monaco Mario A.
Nicholson William H.
LandOfFree
Hypocholesterolemic hydrogenation products and process of prepar does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypocholesterolemic hydrogenation products and process of prepar, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypocholesterolemic hydrogenation products and process of prepar will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-399722